|
27 Oct 2013 |
Medgenics Reports Positive Data with Second-Generation Viral Vectors at European Society of Gene and Cell Therapy Congress
|
|
22 Oct 2013 |
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)
|
|
22 Oct 2013 |
Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
|
|
22 Oct 2013 |
StemCells, Inc. Announces Results of Long-Term Follow-Up Study in Batten Disease
|
|
19 Oct 2013 |
MOLOGEN AG: Clinical study with MGN1404 in malignant melanoma initiated
|
|
17 Oct 2013 |
International Stem Cell Corporation Announces New Data From Parkinson's Disease Program
|
|
17 Oct 2013 |
Rebiotix Begins Clinical Trial of Therapy for the Treatment of Recurrent Clostridium difficile-Associated Diarrhea
|
|
16 Oct 2013 |
Isis Earns $10 Million Milestone Payment from Biogen Idec for Advancement of ISIS-DMPK Rx to Treat Myotonic Dystrophy
|
|
14 Oct 2013 |
Coronado Biosciences Announces Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease
|
